Related Experiment Video

Updated: Jul 17, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Epigenetic inactivation of RASSF1a in uveal melanoma

Willem Maat1, Pieter A van der Velden, Coby Out-Luiting

  • 1Departments of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.

Investigative Ophthalmology & Visual Science
|January 26, 2007
PubMed
Abstract

Insights

RAS association domain family 1a (RASSF1a) gene promoter methylation is common in uveal melanoma, occurring in 91% of cell lines and 50% of primary tumors. This epigenetic event correlates with metastatic disease development.

Area of Science:

  • Oncology
  • Epigenetics
  • Ophthalmology

Background:

  • The RAS association domain family 1 (RASSF1) gene, specifically the RASSF1a transcript, acts as a tumor suppressor.
  • RASSF1a inactivation via hypermethylation is observed in various cancers, including breast, prostate, lung, and melanoma.
  • Uveal melanoma is a primary intraocular malignancy with limited treatment options.

Purpose of the Study:

  • To investigate the methylation status of the RASSF1a promoter in human uveal melanoma.
  • To determine the frequency of RASSF1a promoter methylation in uveal melanoma cell lines and tumor specimens.
  • To explore the correlation between RASSF1a methylation and clinical outcomes, such as metastasis and survival.

Main Methods:

  • Analysis of RASSF1a promoter methylation using PCR, melting curve analysis, sequencing, and restriction enzyme digestion.
  • Study included 11 uveal melanoma cell lines, normal melanocytes, 39 primary uveal melanoma tumors, and one metastatic lesion.
  • Investigated associations between RASSF1a methylation, patient survival, and metastatic disease development.

Main Results:

  • RASSF1a promoter methylation was detected in 91% of uveal melanoma cell lines (10/11).
  • Methylation was present in 50% of primary uveal melanoma tumors (19/38) and the metastatic lesion.
  • A significant positive correlation was observed between RASSF1a promoter methylation and the development of metastatic disease (P=0.041).

Conclusions:

  • RASSF1a promoter methylation is a frequent epigenetic alteration in uveal melanoma.
  • This methylation event may play a role in uveal melanoma pathogenesis and progression.
  • Methylated RASSF1a could serve as a potential diagnostic marker or therapeutic target for uveal melanoma.

More Related Videos

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: